Furthermore, minocycline additionally targets phospholipase A2 and COX2,12 and both enzymes are not modulated by PK2 or PKS antagonist PC1.46 Nevertheless, chronic treatment with either agent similarly and successfully reduced pain in FD animals at both early and advanced disease stages, with effects sustained over time, after just 1 week. This evidence concerns the gene PROK2 and Fabry disease.